The Difference Between Medical Aesthetics and a Day Spa
Not all aesthetics providers are the same — and the differences matter more than you might think, especially during the hormonal changes of perimenopause and menopause. Here is what physician-led care actually means in practice.
This content is for informational purposes only and does not constitute medical advice. Please consult your GP or healthcare provider.
Edmonton has no shortage of places where you can receive "aesthetic treatments." Botox, fillers, and laser procedures are offered in medispas, beauty salons, independent clinics, and dentist offices. From a patient's perspective, it can be genuinely difficult to know what distinguishes them — and why it matters.
The phrase "physician-led aesthetics" is used by London & Glow deliberately, because it describes something specific about how we practise — not just who owns the clinic.
What a Physician Brings That Others Cannot
A physician's training is, at its core, training in clinical reasoning. Before learning any specific procedure, a physician learns to take a history, examine a patient, synthesise information, identify risk factors, formulate a differential diagnosis, and make clinical judgements about treatment.
In the context of aesthetics, this translates to:
A medical assessment before every procedure. At London & Glow, every patient undergoes a medical consultation before any injectable treatment. This includes a full medical history, relevant medications (many of which interact with aesthetic procedures), allergy history, and — crucially for our patient population — a hormonal health history. We ask about your cycle, whether you are in perimenopause, whether you are using HRT, and how your skin has changed over recent years. This information directly shapes the treatment plan.
A day spa or non-physician aesthetics clinic typically does not conduct this assessment. A consent form is not a clinical history.
Anatomical knowledge at the level of medical education. The face contains major arteries, nerves, and lymphatic channels whose exact course must be known to perform filler injections safely. The danger zones for vascular complications — the angular artery, the supratrochlear artery, the infraorbital foramen — are taught in medical anatomy courses. They are not covered in aesthetics training programmes of days or weeks.
The most serious complication of dermal filler treatment is vascular occlusion — inadvertent injection into or compression of an arterial vessel, which can cause skin necrosis and, in rare cases, vision loss. Knowing how to recognise, treat, and refer this complication is not instinctive; it requires clinical training and — ideally — the ability to prescribe hyaluronidase, the enzyme that dissolves HA filler in an emergency.
Prescribing authority and clinical accountability. In Canada, botulinum toxin (Botox, Nuceiva, Dysport) is a prescription-only medication. Legally, it must be prescribed by a licensed prescriber before it can be administered. The extent to which this is enforced varies, but the underlying principle is sound: prescription medicines require a prescriber who can assess appropriateness, contraindications, and risks.
A physician administering botulinum toxin is acting within a regulatory and ethical framework that creates genuine accountability. We are registered with the College of Physicians and Surgeons of Alberta. Our practice is subject to standards and oversight that are simply not present in the aesthetics industry more broadly.
The Menopause-Specific Argument
For women navigating perimenopause or menopause, the case for physician-led care is particularly strong.
Menopausal skin behaves differently under treatment — as we discuss in several articles on this site. The changes in skin thickness, collagen content, hydration, and barrier function all affect how treatments perform and what is likely to be safe and effective. These are medical considerations, not aesthetic ones.
Beyond the skin: many women in their 40s and 50s come to us carrying unanswered questions about their skin changes, their fatigue, their mood shifts. The consultation with a physician — even for aesthetic treatment — can open a conversation about menopause management that a beauty therapist or aesthetics nurse is not positioned to have. We have referred patients to their GPs with specific questions about HRT. We have identified concerns that warranted further investigation. This is what physician involvement makes possible.
What to Look For When Choosing an Aesthetic Provider
We recognise that not everyone in Edmonton will choose London & Glow — and we would rather you make an informed choice than be misled.
When assessing an aesthetic provider, we suggest asking:
- Who is performing the treatment? A registered physician, a nurse under physician supervision, or an independently practising aesthetician? These are fundamentally different levels of clinical accountability.
- What happens if there is a complication? Does the provider have the training and resources to manage an emergency? Do they have access to hyaluronidase? Do they have emergency protocols?
- Is a medical history taken? Not a brief questionnaire — a proper clinical history that includes medications, allergies, and hormonal status.
- Is the provider registered with their professional college? For physicians in Alberta, this means registration with the College of Physicians and Surgeons of Alberta (CPSA), verifiable at cpsa.ca.
Our Commitment
London & Glow was founded on the belief that the aesthetic care available to women in Edmonton should be held to the same standard as any other medical service — because that is exactly what it is. Every patient who walks through our door receives a medical consultation, a personalised treatment plan, and a physician who is accountable for their care.
That is what physician-led aesthetics means in practice.
References
- NICE. (2023). Menopause: diagnosis and management. NICE guideline NG23. National Institute for Health and Care Excellence.
- British Menopause Society. (2022). Menopause and the skin: BMS consensus statement. Post Reproductive Health, 28(4):190–7.
- North American Menopause Society. (2022). The 2022 hormone therapy position statement of The Menopause Society. Menopause, 29(7):767–94.
- Rzepecki AK, et al. (2019). Estrogen-deficient skin: The role of topical therapy. Menopause Review, 18(1):57–65.
- Beleznay K, et al. (2019). Update on avoiding and treating blindness from fillers. Aesthetic Surgery Journal, 39(6):NP35–NP38.